New IBS drug trial aims to tame stomach pain
NCT ID NCT05815602
Summary
This study is testing if a medication called ebastine works better than a commonly used drug called mebeverine at reducing abdominal pain and other symptoms in people with irritable bowel syndrome (IBS). Researchers will enroll about 200 adults with non-constipation IBS to compare how well the two drugs provide relief over 12 weeks of treatment. The main goal is to see if ebastine offers superior symptom control for this chronic digestive condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IBS (IRRITABLE BOWEL SYNDROME) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AZ St-Lucas
RECRUITINGBruges, West-Vlaanderen, 8310, Belgium
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
AZ St-Maarten
RECRUITINGMechelen, Antwerpen, 2800, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
GZA
RECRUITINGAntwerp, Antwerpen, 2000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UZA
RECRUITINGAntwerp, Antwerpen, 2000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UZLeuven
RECRUITINGLeuven, Vlaams-Brabant, 3000, Belgium
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.